Successful endovascular treatment using biopsy forceps for iliac artery stenosis with an organized thrombus

Size: px
Start display at page:

Download "Successful endovascular treatment using biopsy forceps for iliac artery stenosis with an organized thrombus"

Transcription

1 Successful endovascular treatment using biopsy forceps for iliac artery stenosis with an organized thrombus Taisuke Sato 1, Yasuhiro Takahashi 1, Kenta Onodera 1 Reiko Shiomura 1, Hiroki Goda 1, Isamu Fukuizumi 1, Wataru Shimizu 2 1. Department of Cardiology, 2. Department of Cardiovascular Medicine, Nippon Medical School

2 Disclosure Speaker name: Taisuke Sato I have the following potential conflicts of interest to report: Consulting Employment in industry Stockholder of a healthcare company Owner of a healthcare company Other(s) I do not have any potential conflict of interest

3 Case A 77-year-old woman who had hypertension, dyslipidemia, and chronic lymphatic leukemia complained of recurrence of intermittent claudication. She underwent multiple endovascular treatments (EVTs) of the right external iliac artery. During the aforementioned duration, 50-mg clopidogrel was used continuously and 100-mg aspirin was additionally used only 1 month after stent deployment.

4 Case A 77-year-old woman who had hypertension, dyslipidemia, and chronic lymphatic leukemia complained of recurrence of intermittent claudication. She underwent multiple endovascular treatments (EVTs) of the right external iliac artery. During the aforementioned duration, 50-mg clopidogrel was used continuously and 100-mg aspirin was additionally used only 1 month after stent deployment.

5 Case A 77-year-old woman who had hypertension, dyslipidemia, and chronic lymphatic leukemia complained of recurrence of intermittent claudication. She underwent multiple endovascular treatments (EVTs) of the right external iliac artery. During the aforementioned duration, 50-mg clopidogrel was used continuously and 100-mg aspirin was additionally used only 1 month after stent deployment.

6 1 st EVT Right EIA After stenting Right proximal EIA occlusion SMART stent 10.0/60 mm

7 2 nd EVT After stenting PG 35mmHg SMART stent 7.0/40 mm

8 3 rd EVT NSE PTA 5.0/40 mm

9 4 th EVT SAVERX 5.0/20 mm PG 57mmHg

10 Case However, she presented with severe intermittent claudication of the right lower limb again 4 months after the last EVT. Her right ankle-brachial index(abi) was decreased to Therefore, we performed lower extremity angiography.

11 Case However, she presented with severe intermittent claudication of the right lower limb again 4 months after the last EVT. Her right ankle-brachial index(abi) was decreased to Therefore, we performed lower extremity angiography.

12 Case However, she presented with severe intermittent claudication of the right lower limb again 4 months after the last EVT. Her right ankle-brachial index(abi) was decreased to Therefore, we performed lower extremity angiography.

13 Angiography

14 IVUS

15 Case We suspected that the structure was a thrombus, intimal dissection, or another abnormality. Stent deployment or balloon angioplasty for the lesion could disturb the investigation of the cause of the restenosis. Furthermore, we thought that aspiration of the structure would be difficult on the basis of assessment of IVUS findings. Therefore, a biopsy forceps device was used for removal of the structure.

16 Case We suspected that the structure was a thrombus, intimal dissection, or another abnormality. Stent deployment or balloon angioplasty for the lesion could disturb the investigation of the cause of the restenosis. Furthermore, we thought that aspiration of the structure would be difficult on the basis of assessment of IVUS findings. Therefore, a biopsy forceps device was used for removal of the structure.

17 Case We suspected that the structure was a thrombus, intimal dissection, or another abnormality. Stent deployment or balloon angioplasty for the lesion could disturb the investigation of the cause of the restenosis. Furthermore, we thought that aspiration of the structure would be difficult on the basis of assessment of IVUS findings. Therefore, a biopsy forceps device was used for removal of the structure.

18 Case We suspected that the structure was a thrombus, intimal dissection, or another abnormality. Stent deployment or balloon angioplasty for the lesion could disturb the investigation of the cause of the restenosis. Furthermore, we thought that aspiration of the structure would be difficult on the basis of assessment of IVUS findings. Therefore, a biopsy forceps device was used for removal of the structure.

19 Strategy Stent IVUS Structure Biopsy forceps Optimo occlusion catheter

20 Procedure Fluoroscopy IVUS The structure was excised using a biopsy forceps under fluoroscopic and IVUS image guidance.

21 Final angiography

22 IVUS

23 Removed structure Histological diagnosis: Organized thrombus

24 Clinical course after EVT After endovascular treatment, her intermittent claudication had disappeared. Her right ABI was improved from 0.55 to The CYP2C19 genetic polymorphism, which was checked after the last EVT was CYP2C19 (*1/*2) and showed that she was an intermediate metabolizer. Therefore, the clopidogrel dose was increased to 75 mg and dual antiplatelet therapy was performed 1 month after EVT.

25 Clinical course after EVT After endovascular treatment, her intermittent claudication had disappeared. Her right ABI was improved from 0.55 to The CYP2C19 genetic polymorphism, which was checked after the last EVT was CYP2C19 (*1/*2) and showed that she was an intermediate metabolizer. Therefore, the clopidogrel dose was increased to 75 mg and dual antiplatelet therapy was performed 1 month after EVT.

26 Clinical course after EVT After endovascular treatment, her intermittent claudication had disappeared. Her right ABI was improved from 0.55 to The CYP2C19 genetic polymorphism, which was checked after the last EVT was CYP2C19 (*1/*2) and showed that she was an intermediate metabolizer. Therefore, the clopidogrel dose was increased to 75 mg and dual antiplatelet therapy was performed 1 month after EVT.

27 Clinical course after EVT After endovascular treatment, her intermittent claudication had disappeared. Her right ABI was improved from 0.55 to The CYP2C19 genetic polymorphism, which was checked after the last EVT was CYP2C19 (*1/*2) and showed that she was an intermediate metabolizer. Therefore, the clopidogrel dose was increased to 75 mg and dual antiplatelet therapy was performed 1 month after EVT.

28 Discussion In this case, restenosis in the right EIA was repeated many times. Some treatment options such as balloon angioplasty, stent deployment, or aspiration were considered at the fifth recurrence of intermittent claudication. However, the first two methods could disturb the investigation of the cause of the restenosis, and the last method could be ineffective. Removal of the structure by using a biopsy forceps device with concurrent viewing under fluoroscopy and IVUS imaging, which was safely and effectively performed, led to optimal dilation of the lesion without conventional angioplasty and diagnosis of the cause of the restenosis.

29 Discussion In this case, restenosis in the right EIA was repeated many times. Some treatment options such as balloon angioplasty, stent deployment, or aspiration were considered at the fifth recurrence of intermittent claudication. However, the first two methods could disturb the investigation of the cause of the restenosis, and the last method could be ineffective. Removal of the structure by using a biopsy forceps device with concurrent viewing under fluoroscopy and IVUS imaging, which was safely and effectively performed, led to optimal dilation of the lesion without conventional angioplasty and diagnosis of the cause of the restenosis.

30 Discussion In this case, restenosis in the right EIA was repeated many times. Some treatment options such as balloon angioplasty, stent deployment, or aspiration were considered at the fifth recurrence of intermittent claudication. However, the first two methods could disturb the investigation of the cause of the restenosis, and the last method could be ineffective. Removal of the structure by using a biopsy forceps device with concurrent viewing under fluoroscopy and IVUS imaging, which was safely and effectively performed, led to optimal dilation of the lesion without conventional angioplasty and diagnosis of the cause of the restenosis.

31 Discussion This patient was an intermediate metabolizer of CYP2C19. Moreover, 50-mg clopidogrel, whicih was less than the standard dose, was prescribed by her primary care physician for her had blood disorder. The aforementioned factors could possibly induce stent thrombosis.

32 Discussion This patient was an intermediate metabolizer of CYP2C19. Moreover, 50-mg clopidogrel, whicih was less than the standard dose, was prescribed by her primary care physician for her had blood disorder. The aforementioned factors could possibly induce stent thrombosis.

33 Discussion This patient was an intermediate metabolizer of CYP2C19. Moreover, 50-mg clopidogrel, whicih was less than the standard dose, was prescribed by her primary care physician for her had blood disorder. The aforementioned factors could possibly induce stent thrombosis.

34 Conclusion Endovascular treatment using biopsy forceps was safe and effective for the restenotic lesion with an organized thrombus. The cause of the stent thrombosis in the present case might be associated with the intermediate metabolizer of CYP2C19 and the administration of low-dose clopidogrel.

35 Sumida River Fire Works Festival Tokyo Skytree (634 m) Sumo Stadium Hokusai s birth place and the Sumida Hokusai Museum

36 Successful endovascular treatment using biopsy forceps for iliac artery stenosis with an organized thrombus Taisuke Sato 1, Yasuhiro Takahashi 1, Kenta Onodera 1 Reiko Shiomura 1, Hiroki Goda 1, Isamu Fukuizumi 1, Wataru Shimizu 2 1. Department of Cardiology, 2. Department of Cardiovascular Medicine, Nippon Medical School

Successful transcollateral approach for chronic total occlusion of the superficial femoral artery using a side-hole sheath

Successful transcollateral approach for chronic total occlusion of the superficial femoral artery using a side-hole sheath Successful transcollateral approach for chronic total occlusion of the superficial femoral artery using a side-hole sheath Tokyo Kenta Onodera 1, Yasuhiro Takahashi 1, Reiko Shiomura 1, Hiroki Goda 1,

More information

A transvenous intravascular ultrasound-guided technique for chronic total occlusion of a below-the-knee artery

A transvenous intravascular ultrasound-guided technique for chronic total occlusion of a below-the-knee artery A transvenous intravascular ultrasound-guided technique for chronic total occlusion of a below-the-knee artery Yasuhiro Takahashi 1, Reiko Shiomura 1, Erito Furuse 1 Junya Matsuda 1, Taisuke Sato 1, Wataru

More information

Comparison Of Primary Long Stenting Versus Primary Short Stenting For Long Femoropopliteal Artery Disease (PARADE)

Comparison Of Primary Long Stenting Versus Primary Short Stenting For Long Femoropopliteal Artery Disease (PARADE) Comparison Of Primary Long Stenting Versus Primary Short Stenting For Long Femoropopliteal Artery Disease (PARADE) Young-Guk Ko, M.D. Severance Cardiovascular Hospital, Yonsei University Health System,

More information

CHALLENGING ILIAC ACCESSES AND THROMBOSIS PREVENTION

CHALLENGING ILIAC ACCESSES AND THROMBOSIS PREVENTION CHALLENGING ILIAC ACCESSES AND THROMBOSIS PREVENTION ARMANDO MANSILHA MD, PhD, FEBVS UNIVERSITY HOSPITAL - PORTO Disclosure of Interest Speaker name: ARMANDO MANSILHA I have the following potential conflicts

More information

Angiographic dissection pattern and patency outcomes of post balloon angioplasty for SFA lesions -a retrospective multi center analysis-

Angiographic dissection pattern and patency outcomes of post balloon angioplasty for SFA lesions -a retrospective multi center analysis- Angiographic dissection pattern and patency outcomes of post balloon angioplasty for SFA lesions -a retrospective multi center analysis- Masahiko Fujihara Kishiwada Tokushukai Hospital, Osaka, Japan Disclosure

More information

ISR-treatment The Leipzig experience with purely mechanical debulking. Sven Bräunlich Department for Angiology University-Hospital Leipzig, Germany

ISR-treatment The Leipzig experience with purely mechanical debulking. Sven Bräunlich Department for Angiology University-Hospital Leipzig, Germany ISR-treatment The Leipzig experience with purely mechanical debulking Sven Bräunlich Department for Angiology University-Hospital Leipzig, Germany Disclosure Speaker name: Sven Bräunlich I have the following

More information

How do I use mechanical debulking for the treatment of arterial occlusions

How do I use mechanical debulking for the treatment of arterial occlusions How do I use mechanical debulking for the treatment of arterial occlusions Sven Bräunlich, MD Division of Interventional Angiology University-Hospital Leipzig, Germany Disclosure Speaker name: Sven Bräunlich

More information

The Role of Lithotripsy in Solving the Challenges of Vascular Calcium. Thomas Zeller, MD

The Role of Lithotripsy in Solving the Challenges of Vascular Calcium. Thomas Zeller, MD The Role of Lithotripsy in Solving the Challenges of Vascular Calcium Thomas Zeller, MD 1 1 Disclosure Speaker name: Thomas Zeller... I have the following potential conflicts of interest to report: X X

More information

The Crack and Pave technique for highly resistant calcified lesions. Manuela Matschuck MD University Hospital Leipzig Department Angiology

The Crack and Pave technique for highly resistant calcified lesions. Manuela Matschuck MD University Hospital Leipzig Department Angiology The Crack and Pave technique for highly resistant calcified lesions Manuela Matschuck MD University Hospital Leipzig Department Angiology Disclosure Speaker name: Dr. med. Manuela Matschuck I have the

More information

Hybrid surgical treatment of bilateral aorto-femoral occlusion: a clinical case

Hybrid surgical treatment of bilateral aorto-femoral occlusion: a clinical case Hybrid surgical treatment of bilateral aorto-femoral occlusion: a clinical case Chernyavskiy M.,MD,PhD, Chernova D., Zherdev N., Chernov A. Almazov National Medical Research Centre, St.Petersburg, Russia

More information

Zilver PTX Post-Market Surveillance Study of Paclitaxel-Eluting Stents for Treating Femoropopliteal Artery Disease in Japan: 24-Month Results

Zilver PTX Post-Market Surveillance Study of Paclitaxel-Eluting Stents for Treating Femoropopliteal Artery Disease in Japan: 24-Month Results Post-Market Surveillance Study of Paclitaxel-Eluting Stents for Treating Femoropopliteal Artery Disease in Japan: 24-Month Results Hiroyoshi Yokoi, MD, Fukuoka Sannou Hospital Fukuoka, Japan On behalf

More information

Endovascular treatment of severe TASC C and D external iliac artery occlusive disease. SAINT-LEBES Bertrand Toulouse FRANCE

Endovascular treatment of severe TASC C and D external iliac artery occlusive disease. SAINT-LEBES Bertrand Toulouse FRANCE Endovascular treatment of severe TASC C and D external iliac artery occlusive disease SAINT-LEBES Bertrand Toulouse FRANCE Disclosure Speaker name: SAINT-LEBES I have the following potential conflicts

More information

2-YEAR DATA SUPERA POPLITEAL REAL WORLD

2-YEAR DATA SUPERA POPLITEAL REAL WORLD 2-YEAR DATA SUPERA POPLITEAL REAL WORLD Enrique M. San Norberto. Angiology and Vascular Surgery. Valladolid University Hospital. Valladolid. Spain. Disclosure Speaker name: ENRIQUE M. SAN NORBERTO I have

More information

Brachytherapy for In-Stent Restenosis: Is the Concept Still Alive? Matthew T. Menard, M.D. Brigham and Women s Hospital Boston, Massachussetts

Brachytherapy for In-Stent Restenosis: Is the Concept Still Alive? Matthew T. Menard, M.D. Brigham and Women s Hospital Boston, Massachussetts Brachytherapy for In-Stent Restenosis: Is the Concept Still Alive? Matthew T. Menard, M.D. Brigham and Women s Hospital Boston, Massachussetts Disclosure Speaker name: Matthew T. Menard... x I do not have

More information

Comparison of Angiographic Dissection Patterns Caused by Long vs Short Balloons During Balloon Angioplasty for Chronic Femoropopliteal Occlusions

Comparison of Angiographic Dissection Patterns Caused by Long vs Short Balloons During Balloon Angioplasty for Chronic Femoropopliteal Occlusions Comparison of Angiographic Dissection Patterns Caused by Long vs Short Balloons During Balloon Angioplasty for Chronic Femoropopliteal Occlusions Michinao Tan, MD Tokeidai Memorial Hospital Cardiovascular

More information

PATIENT SPECIFIC STRATEGIES IN CRITICAL LIMB ISCHEMIA. Dr. Manar Trab Consultant Vascular Surgeon European Vascular Clinic DMCC Dubai, UAE

PATIENT SPECIFIC STRATEGIES IN CRITICAL LIMB ISCHEMIA. Dr. Manar Trab Consultant Vascular Surgeon European Vascular Clinic DMCC Dubai, UAE PATIENT SPECIFIC STRATEGIES IN CRITICAL LIMB ISCHEMIA Dr. Manar Trab Consultant Vascular Surgeon European Vascular Clinic DMCC Dubai, UAE Disclosure Speaker name: DR. Manar Trab I have the following potential

More information

Drug-Coated Balloon Treatment for Patients with Intermittent Claudication: Insights from the IN.PACT Global Full Clinical Cohort

Drug-Coated Balloon Treatment for Patients with Intermittent Claudication: Insights from the IN.PACT Global Full Clinical Cohort Drug-Coated Balloon Treatment for Patients with Intermittent Claudication: Insights from the IN.PACT Global Full Clinical Cohort a.o. Univ. Prof. Dr. Marianne Brodmann Medical University of Graz Graz,

More information

The Fate of Unexpected Events Occurring in Standard EVAR

The Fate of Unexpected Events Occurring in Standard EVAR The Fate of Unexpected Events Occurring in Standard EVAR Andrea Stella Alma Mater Studiorum - University of Bologna Disclosure Speaker name: Prof. Andrea Stella I have the following potential conflicts

More information

Hybrid Procedures for Peripheral Obstructive Disease - Step by Step -

Hybrid Procedures for Peripheral Obstructive Disease - Step by Step - Hybrid Procedures for Peripheral Obstructive Disease - Step by Step - Holger Staab, MD University Hospital Leipzig, Germany Clinic for Vascular Surgery Disclosure Speaker name:..holger Staab... I have

More information

Long-term Zilver PTX Data from Japan: 5-year Results in the Real World

Long-term Zilver PTX Data from Japan: 5-year Results in the Real World Long-term Data from Japan: 5-year Results in the Real World Hiroyoshi Yokoi, MD Department of Cardiovascular Medicine Fukuoka Sanno Hospital Fukuoka, Japan On behalf of the Investigators Disclosure Speaker

More information

The results of EVT for Chronic Aortic Occlusion - a multicenter retrospective study - Taku Kato, MD Rakuwakai Otowa Hospital, Kyoto, Japan

The results of EVT for Chronic Aortic Occlusion - a multicenter retrospective study - Taku Kato, MD Rakuwakai Otowa Hospital, Kyoto, Japan The results of EVT for Chronic Aortic Occlusion - a multicenter retrospective study - Taku Kato, MD Rakuwakai Otowa Hospital, Kyoto, Japan COI disclosure Disclosure Speaker name: Taku Kato... I have the

More information

Klinikum Rosenheim Department of Diagnostic and Interventional Radiology

Klinikum Rosenheim Department of Diagnostic and Interventional Radiology Klinikum Rosenheim Department of Diagnostic and Interventional Radiology Is Directional Atherectomy (Silverhawk Or Turbohawk) With DEB, Better Than DEB Alone: Based On The DEFINITIVE AR RCT: 1-Year Results

More information

Chimney technique combined with aortoiliac stenting for the treatment. disease. of juxtarenal aortoiliac occlusive

Chimney technique combined with aortoiliac stenting for the treatment. disease. of juxtarenal aortoiliac occlusive Chimney technique combined with aortoiliac stenting for the treatment of juxtarenal aortoiliac occlusive disease Suwanruangsri Veera,MD Kaviros Pruesttipong,MD Department of Surgery, Maharat Nakhon Ratchasima

More information

Anticoagulation therapy following endovascular treatment of iliofemoral deep vein thrombosis

Anticoagulation therapy following endovascular treatment of iliofemoral deep vein thrombosis Anticoagulation therapy following endovascular treatment of iliofemoral deep vein thrombosis Tim Sebastian, M.D. University Hospital Zurich Clinic for Angiology Disclosure Speaker name: Tim Sebastian I

More information

SFA CTO Lesion Management laser or directional atherectomy?

SFA CTO Lesion Management laser or directional atherectomy? SFA CTO Lesion Management laser or directional atherectomy? Kevin, Chung-Ho Hsu, M.D. Setion of Peripheral Vascular Disease, Division of Cardiology, China Medical University Hospital, Taichung, Taiwan

More information

ILLUMENATE FIH Direct DCB Cohort 12-Month Results

ILLUMENATE FIH Direct DCB Cohort 12-Month Results ILLUMENATE FIH Direct DCB Cohort 12-Month Results Stephan Duda Berlin Study Investigators: H. Schröder (PI), B. Lux, F. Rücker, M. Martorana, D. Meyer, H. Hartmann, S. Duda Disclosure Speaker name: S.

More information

Dealing with Calcification in BTK Arteries: Is Lithoplasty the Answer?

Dealing with Calcification in BTK Arteries: Is Lithoplasty the Answer? Dealing with Calcification in BTK Arteries: Is Lithoplasty the Answer? Andrew Holden, MBChB, FRANZCR, EBIR Director of Interventional Radiology Auckland, New Zealand LINC 2017 January 25 th 2017 Disclosure

More information

DCB in my practice: How the evidence influences my strategy. Yang-Jin Park

DCB in my practice: How the evidence influences my strategy. Yang-Jin Park DCB in my practice: How the evidence influences my strategy Yang-Jin Park Associate Professor Division of Vascular Surgery, Department of Surgery Samsung Medical Center Sungkyunkwan University School of

More information

Bifurcation stenting with BVS

Bifurcation stenting with BVS Bifurcation stenting with BVS Breaking the limits or just breaking the struts? Maciej Lesiak Department of Cardiology University Hospital in Poznan, Poland Disclosure Speaker s name: Maciej Lesiak I have

More information

Stents for The Common Femoral Artery: The Good, The Bad and The Ugly

Stents for The Common Femoral Artery: The Good, The Bad and The Ugly Stents for The Common Femoral Artery: The Good, The Bad and The Ugly Salman Arain, MD, FACC Assistant Professor of Medicine - Cardiology University of Texas Health Sciences Center Houston Texas, USA Disclosure

More information

Thoracic Endovascular Aortic Repair (TEVAR) Indications and Basic Procedure

Thoracic Endovascular Aortic Repair (TEVAR) Indications and Basic Procedure Thoracic Endovascular Aortic Repair (TEVAR) Indications and Basic Procedure Tilo Kölbel, MD, PhD University Heart Center Hamburg University Hospital Eppendorf Disclosure Speaker name: Tilo Kölbel, MD I

More information

Endovascular treatment of acquired arteriovenous fistula with severe hemodynamic effects: a case report

Endovascular treatment of acquired arteriovenous fistula with severe hemodynamic effects: a case report Endovascular treatment of acquired arteriovenous fistula with severe hemodynamic effects: a case report The Leipzig Interventional Course, January 24 27, 2017 El Samman K., Šedivý P., Šnajdrová A., Přindišová

More information

Step by step Hybrid procedures in peripheral obstructive disease. Holger Staab, MD University Hospital Leipzig, Germany Clinic for Vascular Surgery

Step by step Hybrid procedures in peripheral obstructive disease. Holger Staab, MD University Hospital Leipzig, Germany Clinic for Vascular Surgery Step by step Hybrid procedures in peripheral obstructive disease Holger Staab, MD University Hospital Leipzig, Germany Clinic for Vascular Surgery Disclosure Speaker name: H.H. Staab I have the following

More information

Vascular Surgery and Transplant Unit University of Catania. Pierfrancesco Veroux

Vascular Surgery and Transplant Unit University of Catania. Pierfrancesco Veroux Vascular Surgery and Transplant Unit University of Catania Pierfrancesco Veroux Bologna-Palazzo dei Congressi, 23 Ottobre 2017 Disclosure Speaker name: Prof. Pierfrancesco Veroux I have the following potential

More information

How to best approach chronic venous occlusions?

How to best approach chronic venous occlusions? How to best approach chronic venous occlusions? Prof. Nils Kucher Director Venous Thromboembolism Reseach Group University Hospital Bern nilskucher.com Disclosure Speaker name: Nils Kucher X X I have the

More information

Copyright HMP Communications

Copyright HMP Communications Treatment of Angioseal-Related Femoral Artery Occlusion Using TurboHawk Directional Atherectomy Anvar Babaev, MD, PhD; David W. Lee, MD; Anna Kurayev, MD; Heather Yang, PA From the Division of Cardiology,

More information

OCT Guided Atherectomy: Initial Results of the VISION Trial Using the Pantheris Catheter. Patrick Muck, MD

OCT Guided Atherectomy: Initial Results of the VISION Trial Using the Pantheris Catheter. Patrick Muck, MD OCT Guided Atherectomy: Initial Results of the VISION Trial Using the Pantheris Catheter Patrick Muck, MD Chief, Division of Vascular Surgery Good Samaritan Hospital Cincinna

More information

KEN-ICHIRO SASAKI, HIDETOSHI CHIBANA, TAKAFUMI UENO, NAOKI ITAYA, MASAHIRO SASAKI AND YOSHIHIRO FUKUMOTO

KEN-ICHIRO SASAKI, HIDETOSHI CHIBANA, TAKAFUMI UENO, NAOKI ITAYA, MASAHIRO SASAKI AND YOSHIHIRO FUKUMOTO Case Report This is Advance Publication Article Kurume Medical Journal, 63, 39-43, 2016 Successful Endovascular Treatment of Aortoiliac Bifurcation Stenosis Using an Empirically Based T and Protrude-Stenting

More information

Hypothesis: When compared to conventional balloon angioplasty, cryoplasty post-dilation decreases the risk of SFA nses in-stent restenosis

Hypothesis: When compared to conventional balloon angioplasty, cryoplasty post-dilation decreases the risk of SFA nses in-stent restenosis Cryoplasty or Conventional Balloon Post-dilation of Nitinol Stents For Revascularization of Peripheral Arterial Segments Background: Diabetes mellitus is associated with increased risk of in-stent restenosis

More information

The latest evidences from the DES trials in peripheral arterial disease

The latest evidences from the DES trials in peripheral arterial disease The latest evidences from the DES trials in peripheral arterial disease Michael D. Dake, MD Thelma and Henry Doelger Professor Stanford University School of Medicine Disclosure Speaker name: Michael D.

More information

Update from Korea on the Lutonix SFA registry 12 month data

Update from Korea on the Lutonix SFA registry 12 month data Update from Korea on the Lutonix SFA registry 12 month data Prospective, Multicenter, Post-Market Registy Assessing the Clinical Use and Safety of the Lutonix Drug Coated Balloon in Femoropopliteal Arteries

More information

The relation of 2D perfusion angiography after BTK intervention and wound healing in patient with CLI - Single center prospective study -

The relation of 2D perfusion angiography after BTK intervention and wound healing in patient with CLI - Single center prospective study - The relation of 2D perfusion angiography after BTK intervention and wound healing in patient with CLI - Single center prospective study - Shinya Sasaki, MD. Saka General Hospital Miyagi, JAPAN Disclosure

More information

Koen Keirse, MD RZ Tienen, Belgium

Koen Keirse, MD RZ Tienen, Belgium Clinical Benefits of the Vanguard IEP Peripheral Balloon Angioplasty System with Integrated Embolic Protection from the ENTRAP Study Koen Keirse, MD RZ Tienen, Belgium Disclosure Speaker name: Koen Keirse...

More information

Massimiliano Fusaro, MD on behalf of ISAR-STATH Investigators. Deutsches Herzzentrum München, Technische Universität München Munich - Germany

Massimiliano Fusaro, MD on behalf of ISAR-STATH Investigators. Deutsches Herzzentrum München, Technische Universität München Munich - Germany Intravascular Stenting and Angiographic Results: Randomized Comparison of STenting, Stenting after Paclitaxel-eluting balloon and ATHerectomy in patients with symptomatic Peripheral Artery Disease - Results

More information

Challenges. 1. Sizing. 2. Proximal landing zone 3. Distal landing zone 4. Access vessels 5. Spinal cord ischemia 6. Endoleak

Challenges. 1. Sizing. 2. Proximal landing zone 3. Distal landing zone 4. Access vessels 5. Spinal cord ischemia 6. Endoleak Disclosure I have the following potential conflicts of interest to report: Consulting: Medtronic, Gore Employment in industry Stockholder of a healthcare company Owner of a healthcare company Other(s)

More information

Shockwave Medical Lithoplasty. Thomas Zeller MD Universitäts-Herzzentrum Freiburg & Bad Krozingen, Germany

Shockwave Medical Lithoplasty. Thomas Zeller MD Universitäts-Herzzentrum Freiburg & Bad Krozingen, Germany Shockwave Medical Lithoplasty Thomas Zeller MD Universitäts-Herzzentrum Freiburg & Bad Krozingen, Germany Disclosure Speaker name: Thomas Zeller, MD I have the following potential conflicts of interest

More information

VIRTUS: Trial Design and Primary Endpoint Results

VIRTUS: Trial Design and Primary Endpoint Results VIRTUS: Trial Design and Primary Endpoint Results Mahmood K. Razavi, MD St. Joseph Cardiac and Vascular Center Orange, CA, USA IMPORTANT INFORMATION: These materials are intended to describe common clinical

More information

Variation of stent placement for distal abdominal aorta Lesion

Variation of stent placement for distal abdominal aorta Lesion Variation of stent placement for distal abdominal aorta Lesion Tatsuki Doijiri M.D Department of Cardiology Yamato-Seiwa Hospital Kanagawa Japan Disclosure Speaker name: Tatsuki Doijiri... I have the following

More information

Treating In-Stent Restenosis with Brachytherapy: Does it Actually Work?

Treating In-Stent Restenosis with Brachytherapy: Does it Actually Work? Treating In-Stent Restenosis with Brachytherapy: Does it Actually Work? Matthew T. Menard, M.D. Brigham and Women s Hospital Pacific Northwest Endovascular Conference June 15, 2018 DISCLOSURE Matthew Menard,

More information

IVUS Guided Case Review Case Performed by Frank R. Arko III, MD Charlotte, NC

IVUS Guided Case Review Case Performed by Frank R. Arko III, MD Charlotte, NC IVUS Guided Case Review Case Performed by Frank R. Arko III, MD Charlotte, NC The opinions and clinical experiences presented herein are for informational purposes only. Dr. Arko is a paid consultant for

More information

The role of bioabsorbable stents in the superficial femoral artery What is going on? Frank Vermassen Ghent University Hospital Belgium

The role of bioabsorbable stents in the superficial femoral artery What is going on? Frank Vermassen Ghent University Hospital Belgium The role of bioabsorbable stents in the superficial femoral artery What is going on? Frank Vermassen Ghent University Hospital Belgium Disclosures Speaker name: Frank Vermassen I have the following potential

More information

2 Year Results from the MDT SFA Japan Trial - DCB vs. standard PTA for the treatment of atherosclerotic lesions in the SFA/PPA

2 Year Results from the MDT SFA Japan Trial - DCB vs. standard PTA for the treatment of atherosclerotic lesions in the SFA/PPA 2 Year Results from the MDT- 2113 SFA Japan Trial - DCB vs. standard PTA for the treatment of atherosclerotic lesions in the SFA/PPA Osamu Iida, MD - Kansai Rosai Hospital, Hyogo, Japan Hiroyoshi Yokoi,

More information

Future Algorithm for Lower Extremity Revascularization: Where Does Vessel Prep Fit?

Future Algorithm for Lower Extremity Revascularization: Where Does Vessel Prep Fit? Future Algorithm for Lower Extremity Revascularization: Where Does Vessel Prep Fit? John R. Laird Adventist Heart and Vascular Institute St. Helena, CA Disclosure Speaker name: John R. Laird... I have

More information

Outcomes Of DCB Use In Real World Registries: 2 Year Results From The INPACT Global Registry

Outcomes Of DCB Use In Real World Registries: 2 Year Results From The INPACT Global Registry Outcomes Of DCB Use In Real World Registries: 2 Year Results From The INPACT Global Registry Marianne Brodmann, MD Head of the Clinical Division of Angiology Department of Internal Medicine Medical University

More information

Excimer Laser angioplasty for femoro-popliteal disease. Sendai Kousei Hospital, Tokyo Kamata Hospital Naoto Inoue MD, FSCAI, FJCC, FAHA

Excimer Laser angioplasty for femoro-popliteal disease. Sendai Kousei Hospital, Tokyo Kamata Hospital Naoto Inoue MD, FSCAI, FJCC, FAHA Excimer Laser angioplasty for femoro-popliteal disease Sendai Kousei Hospital, Tokyo Kamata Hospital Naoto Inoue MD, FSCAI, FJCC, FAHA Speaker s name: Naoto Inoue I have the following potential conflicts

More information

Promise and limitations of DCB in long lesions What Have we Learned from Clinical Trials? Ramon L. Varcoe, MBBS, MS, FRACS, PhD

Promise and limitations of DCB in long lesions What Have we Learned from Clinical Trials? Ramon L. Varcoe, MBBS, MS, FRACS, PhD Promise and limitations of DCB in long lesions What Have we Learned from Clinical Trials? Ramon L. Varcoe, MBBS, MS, FRACS, PhD Associate Professor of Vascular Surgery University of New South Wales Sydney,

More information

Expanding to every demand: The GORE VIABAHN VBX Stent Graft

Expanding to every demand: The GORE VIABAHN VBX Stent Graft Expanding to every demand: The GORE VIABAHN VBX Stent Graft GORE, VIABAHN, and designs are trademarks of W. L. Gore & Associates. 2017 W. L. Gore & Associates, Inc. Program Faculty Martin Austermann, MD

More information

Challenging of contrast agent-free endovascular treatment using 3D imaging

Challenging of contrast agent-free endovascular treatment using 3D imaging AC17-0010 Challenging of contrast agent-free endovascular treatment using 3D imaging Amane Kozuki Department of Cardiology, Osaka Saiseikai Nakatsu Hospital Introduction With advances in devices and techniques,

More information

The essentials for BTK procedures: wires, balloons, what else

The essentials for BTK procedures: wires, balloons, what else A comprehensive approach to diabetic patient Tx The essentials for BTK procedures: wires, balloons, what else Dai-Do Do Clinical and Interventional Angiology Cardiovascular Department Disclosure Speaker

More information

Catheter-Directed Thrombolysis for Acute Limb Ischemia. Hwan Jun Jae MD Seoul National University Hospital Seoul, Korea

Catheter-Directed Thrombolysis for Acute Limb Ischemia. Hwan Jun Jae MD Seoul National University Hospital Seoul, Korea Catheter-Directed Thrombolysis for Acute Limb Ischemia Hwan Jun Jae MD Seoul National University Hospital Seoul, Korea Disclosure Speaker name: Hwan Jun Jae... I have the following potential conflicts

More information

Novel distal popliteal artery puncture technique in supine position for chronic femoropopliteal arterial occlusion; frontal popliteal puncture

Novel distal popliteal artery puncture technique in supine position for chronic femoropopliteal arterial occlusion; frontal popliteal puncture Novel distal popliteal artery puncture technique in supine position for chronic femoropopliteal arterial occlusion; frontal popliteal puncture Miyazaki Medical Association Hospital Cardiovascular Center

More information

Accurate Vessel Sizing Drives Clinical Results. IVUS In the Periphery

Accurate Vessel Sizing Drives Clinical Results. IVUS In the Periphery Accurate Vessel Sizing Drives Clinical Results IVUS In the Periphery Discussion Iida O, et. al. Study Efficacy of Intravascular Ultrasound in Femoropopliteal Stenting for Peripheral Artery Disease With

More information

3-year results of the OLIVE registry:

3-year results of the OLIVE registry: 3-year results of the OLIVE registry: A prospective multicenter study in patients with critical limb ischemia Osamu Iida, MD Kansai Rosai Hospital Cardiovascular Center Amagasaki, Hyogo, Japan Disclosure

More information

Final Results of the Feasibility Study for the Drug-coated Chocolate Touch PTA balloon. (The ENDURE Trial)

Final Results of the Feasibility Study for the Drug-coated Chocolate Touch PTA balloon. (The ENDURE Trial) Final results of the feasibility study for the drug-coated Chocolate Touch PTA balloon of of femoropopliteal Femoropopliteal lesions lesions: (The ENDURE Trial) Final Results of the Feasibility Study for

More information

Predictors of restenosis and cardiovascular events in patients undergoing percutaneous angioplasty for subclavian/innominate artery stenosis

Predictors of restenosis and cardiovascular events in patients undergoing percutaneous angioplasty for subclavian/innominate artery stenosis Predictors of restenosis and cardiovascular events in patients undergoing percutaneous angioplasty for subclavian/innominate artery stenosis Tadeusz Przewlocki, Anna Kablak Ziembicka, Piotr Pieniazek,

More information

TOBA Trial 12 months Results

TOBA Trial 12 months Results Tack Optimized Balloon Angioplasty: TOBA Trial 12 months Results New Paradigm for Managing Post PTA Dissections Marc Bosiers, MD A.Z. St. Blasius Hospital, Belgium Disclosure Speaker name: Dr. Marc Bosiers

More information

PES BTK 70 : 12 m results with a paclitaxelcoated self-expanding stent in BTK arteries

PES BTK 70 : 12 m results with a paclitaxelcoated self-expanding stent in BTK arteries LINC 2015, Leipzig A.Z. Sint-Blasius, Dendermonde Marc Bosiers Koen Deloose Joren Callaert Imelda Hospital, Bonheiden Patrick Peeters Jürgen Verbist OLV Hospital, Aalst Lieven Maene Roel Beelen R.Z. Heilig

More information

New Evidence from Laser + Drug Coated Balloons for Treatment of In-Stent Restenosis

New Evidence from Laser + Drug Coated Balloons for Treatment of In-Stent Restenosis New Evidence from Laser + Drug Coated Balloons for Treatment of In-Stent Restenosis Ehrin J. Armstrong, MD MSc Director, Interventional Cardiology VA Eastern Colorado Healthcare System Associate Professor

More information

Final Results of the Feasibility Study for the Drug-coated Chocolate Touch PTA balloon. (The ENDURE Trial)

Final Results of the Feasibility Study for the Drug-coated Chocolate Touch PTA balloon. (The ENDURE Trial) Final results of the feasibility study for the drug-coated Chocolate Touch PTA balloon of of femoropopliteal Femoropopliteal lesions lesions: (The ENDURE Trial) Final Results of the Feasibility Study for

More information

In-Stent Restenosis: New Evidence From Laser + Drug Coated Balloons

In-Stent Restenosis: New Evidence From Laser + Drug Coated Balloons In-Stent Restenosis: New Evidence From Laser + Drug Coated Balloons Ehrin J. Armstrong, MD MSc Director, Interventional Cardiology VA Eastern Colorado Healthcare System Associate Professor of Medicine

More information

Management of In-stent Restenosis after Lower Extremity Endovascular Procedures

Management of In-stent Restenosis after Lower Extremity Endovascular Procedures Management of In-stent Restenosis after Lower Extremity Endovascular Procedures Piotr Sobieszczyk, MD Associate Director, Cardiac Catheterization Laboratory Cardiovascular Division and Vascular Medicine

More information

Image-Guided Approach to Treatment of Patients with Nonthrombotic

Image-Guided Approach to Treatment of Patients with Nonthrombotic Image-Guided Approach to Treatment of Patients with Nonthrombotic May Thurner Syndrome Brian DeRubertis, MD, FACS Associate Professor of Surgery Division of Vascular Surgery UCLA School of Medicine Los

More information

PRISM Trial. Retrospective Case Review of Technical Success Using the Penumbra and Indigo Systems for Mechanical Thrombectomy in the Periphery

PRISM Trial. Retrospective Case Review of Technical Success Using the Penumbra and Indigo Systems for Mechanical Thrombectomy in the Periphery PRISM Trial Retrospective Case Review of Technical Success Using the Penumbra and Indigo Systems for Mechanical Thrombectomy in the Periphery George L. Adams, MD, MHS, FACC, FSCAI Clinical Associate Professor

More information

Prospective, randomized controlled study of paclitaxel-coated versus plain balloon angioplasty for the treatment of failing dialysis access

Prospective, randomized controlled study of paclitaxel-coated versus plain balloon angioplasty for the treatment of failing dialysis access Prospective, randomized controlled study of paclitaxel-coated versus plain balloon angioplasty for the treatment of failing dialysis access Disclosure Speaker name:... I have the following potential conflicts

More information

TOBA II 12-Month Results Tack Optimized Balloon Angioplasty

TOBA II 12-Month Results Tack Optimized Balloon Angioplasty TOBA II 12-Month Results Tack Optimized Balloon Angioplasty William Gray, MD System Chief, Cardiovascular Division Main Line Health, Philadelphia, PA Dissection: The Primary Mechanism of Angioplasty Lesions

More information

Peripheal artery occlusive disease(from aorta to popliteal) 연세대학교의과대학 심장혈관병원최동훈

Peripheal artery occlusive disease(from aorta to popliteal) 연세대학교의과대학 심장혈관병원최동훈 Peripheal artery occlusive disease(from aorta to popliteal) 연세대학교의과대학 심장혈관병원최동훈 Case 1 Aorta disease -antegrade via brachial artery, subintimal approach, wire retraction, kissing stent- M / 59 # 4268376

More information

Atherectomy: Jetstream and Directional. George S. Chrysant, M.D.

Atherectomy: Jetstream and Directional. George S. Chrysant, M.D. Atherectomy: Jetstream and Directional George S. Chrysant, M.D. Disclosures Abbott Vascular: MAB, consultant, proctor Abiomed: consultant Boston Scientific: MAB, consultant, proctor Medicines Company:

More information

The Role of LUTONIX 035 DCB in AV Fistula Dysfunction Management in our Practice

The Role of LUTONIX 035 DCB in AV Fistula Dysfunction Management in our Practice The Role of LUTONIX 035 DCB in AV Fistula Dysfunction Management in our Practice Dr Kate Steiner Consultant Interventional Radiologist East and North Hertfordshire NHS Trust Disclosure Speaker name: Dr

More information

Safety and Efficacy of Distal Superficial Femoral Artery Puncture for Femoropopliteal Occlusive Lesions

Safety and Efficacy of Distal Superficial Femoral Artery Puncture for Femoropopliteal Occlusive Lesions Safety and Efficacy of Distal Superficial Femoral Artery Puncture for Femoropopliteal Occlusive Lesions ~Result form the Multicenter RIVERside registry~ Tatsuya Nakama, Y Yamamoto, A Matsui, T Doijiri,

More information

Lutonix in AV fistula and Early look AV IDE trial data

Lutonix in AV fistula and Early look AV IDE trial data Lutonix in AV fistula and Early look AV IDE trial data Jackie P Ho Dept of Cardiac, Thoracic & Vascular Surgery National University of Singapore NUHS, Singapore Lutonix in AV fistula and final AV IDE trial

More information

Rotarex mechanical debulking: The Leipzig experience in patients

Rotarex mechanical debulking: The Leipzig experience in patients Rotarex mechanical debulking: The Leipzig experience in 1.200+ patients Dierk Scheinert, MD Division of Interventional Angiology University-Hospital Leipzig, Germany Disclosure Speaker name: Dierk Scheinert

More information

Aspirex for Upper and Lower Extremity DVT

Aspirex for Upper and Lower Extremity DVT Aspirex for Upper and Lower Extremity DVT Steven Kum MD Vascular & Endovascular Surgeon Director of Vascular Service Changi General Hospital Singapore Disclosure Speaker name:... I have the following potential

More information

Endovascular and Hybrid Treatment of TASC C & D Aortoiliac Occlusive Disease

Endovascular and Hybrid Treatment of TASC C & D Aortoiliac Occlusive Disease Endovascular and Hybrid Treatment of TASC C & D Aortoiliac Occlusive Disease Arash Bornak, MD FACS Vascular & Endovascular Surgery University of Miami Miller School of Medicine No disclosure BACKGROUND

More information

PATIENTS WITH CLI THE THREE YEARS OUTCOME OF ENDOLUMINAL BYPASS FOR PATIENTS WITH CLI

PATIENTS WITH CLI THE THREE YEARS OUTCOME OF ENDOLUMINAL BYPASS FOR PATIENTS WITH CLI JORGE FERNÁNDEZ NOYA ANGIOLOGY AND VASCULAR SURGERY DEPARTMENT UNIVERSITARY CLINICAL HOSPITAL SANTIAGO DE COMPOSTELA THE THREE YEARS OUTCOME OF ENDOLUMINAL BYPASS FOR Disclosure Speaker name: Jorge Fernández

More information

Treatment options of late failures of EVAS. Michel Reijnen Rijnstate Arnhem The Netherlands

Treatment options of late failures of EVAS. Michel Reijnen Rijnstate Arnhem The Netherlands Treatment options of late failures of EVAS Michel Reijnen Rijnstate Arnhem The Netherlands Disclosure Speaker name: Michel Reijnen I have the following potential conflicts of interest to report: Consulting

More information

Clinical benefits on DES Patient s perspectives

Clinical benefits on DES Patient s perspectives Clinical benefits on DES Patient s perspectives Dr. Skyi Pang Vascular Surgeon Department of Surgery Pamela Youde Nethersole Eastern Hospital Hong Kong Disclosure Speaker name: Skyi Pang... I have the

More information

Atherectomy is Still Live and Effective. John R. Laird, MD Professor of Medicine Medical Director of the Vascular Center UC Davis Health System

Atherectomy is Still Live and Effective. John R. Laird, MD Professor of Medicine Medical Director of the Vascular Center UC Davis Health System Atherectomy is Still Live and Effective John R. Laird, MD Professor of Medicine Medical Director of the Vascular Center UC Davis Health System Why is Atherectomy Still Alive? Improved devices Better data

More information

Aortoiliac stenting: is CERAB replacing kissing stents from a flow dynamic perspective? Michel MPJ Reijnen Rijnstate Hospital Arnhem, The Netherlands

Aortoiliac stenting: is CERAB replacing kissing stents from a flow dynamic perspective? Michel MPJ Reijnen Rijnstate Hospital Arnhem, The Netherlands Aortoiliac stenting: is CERAB replacing kissing stents from a flow dynamic perspective? Michel MPJ Reijnen Rijnstate Hospital Arnhem, The Netherlands Disclosure Speaker name: MMPJ Reijnen I have the following

More information

Subclavian artery Stenting

Subclavian artery Stenting Subclavian artery Stenting Etiology Atherosclerosis Takayasu s arteritis Fibromuscular dysplasia Giant Cell Arteritis Radiation-induced Vascular Injury Thoracic Outlet Syndrome Neurofibromatosis Incidence

More information

Adventitial Drug Therapy Below-the-Knee: Update on LIMBO and TANGO

Adventitial Drug Therapy Below-the-Knee: Update on LIMBO and TANGO Adventitial Drug Therapy Below-the-Knee: Update on LIMBO and TANGO Ehrin J. Armstrong, MD, FACC University of Colorado School of Medicine VA Eastern Colorado Healthcare System Denver, Colorado, USA Disclosure

More information

Simultaneous Acute ST Elevation Myocardial Infarction And Acute Left Subclavian Artery Thrombosis

Simultaneous Acute ST Elevation Myocardial Infarction And Acute Left Subclavian Artery Thrombosis Simultaneous Acute ST Elevation Myocardial Infarction And Acute Left Subclavian Artery Thrombosis Chee Yang CHIN, MBChB, MRCP(UK) C.W.L. Chin, P.T.L. Chiam, R.S. Tan National Heart Centre Singapore 26

More information

The Supera stent In retrograde vascular access for SFA ostium treatment: The SUPRA-FAST Registry

The Supera stent In retrograde vascular access for SFA ostium treatment: The SUPRA-FAST Registry The Supera stent In retrograde vascular access for SFA ostium treatment: PESTRICHELLA VINCENZO MD Chief Endovascular cathlab Mater Dei Hospital BARI- Italy Disclosure Speaker name:...pestrichella VINCENZO...

More information

Why and how to prep the vessel

Why and how to prep the vessel Why and how to prep the vessel Drug elution in the SFA: Leave the right thing behind. Debating evidence to provide an answer Erwin Blessing, MD, FESC SRH Klinikum Karlsbad-Langensteinbach Germany Disclosure

More information

Next Generation of DCB: Efficacy and tolerance of drug-coated hyper-compliant balloons (DCHCB) in peripheral arteries of swine

Next Generation of DCB: Efficacy and tolerance of drug-coated hyper-compliant balloons (DCHCB) in peripheral arteries of swine Next Generation of DCB: Efficacy and tolerance of drug-coated hyper-compliant balloons (DCHCB) in peripheral arteries of swine Maciej Kusmierczuk 1 ; Stephanie Bienek, PhD 1 ; Sebastian Schurmann 1 ; Antje

More information

BTK Case Studies Joseph Cardenas, MD AZ Heart & Vascular, Yuma, AZ

BTK Case Studies Joseph Cardenas, MD AZ Heart & Vascular, Yuma, AZ BTK Case Studies Joseph Cardenas, MD AZ Heart & Vascular, Yuma, AZ 1 Case 1 78 yr. old female Rutherford Class II/III lesion 1 block claudicant 2 Pre Treatment Post Treatment Anterior Tibial Artery Occlusion

More information

Internal iliac artery angioplasty for the treatment of buttock claudication and erectile dysfunction: a systematic review

Internal iliac artery angioplasty for the treatment of buttock claudication and erectile dysfunction: a systematic review Internal iliac artery angioplasty for the treatment of buttock claudication and erectile dysfunction: a systematic review K Pate l 1, U Beschorner 2, P H o l t 1, K S r i t h aran 1 1 S t G e o r g e s

More information

Anatomical challenges in EVAR

Anatomical challenges in EVAR Anatomical challenges in EVAR M.H. EL DESSOKI, MD,FRCS PROFESSOR OF VASCULAR SURGERY CAIRO UNIVERSITY Disclosure Speaker name:... I have the following potential conflicts of interest to report: Consulting

More information

Technical Aspects for Treating AV Dialysis Fistulae with the IN.PACT DCB. Andrew Holden Auckland Hospital Auckland, New Zealand

Technical Aspects for Treating AV Dialysis Fistulae with the IN.PACT DCB. Andrew Holden Auckland Hospital Auckland, New Zealand Technical Aspects for Treating AV Dialysis Fistulae with the IN.PACT DCB Andrew Holden Auckland Hospital Auckland, New Zealand LINC 2017 26 th January 2017 Disclosure Speaker name: Andrew Holden I have

More information

How Do We Optimize the Medical Therapy of Patients with Critical Limb Ischemia?

How Do We Optimize the Medical Therapy of Patients with Critical Limb Ischemia? How Do We Optimize the Medical Therapy of Patients with Critical Limb Ischemia? Ehrin J. Armstrong, MD MSc MAS Director, Interventional Cardiology Director, Vascular Laboratory VA Eastern Colorado Healthcare

More information

A multidisciplinary team approach for vascular disease: The role of cardiologists and vascular specialists

A multidisciplinary team approach for vascular disease: The role of cardiologists and vascular specialists A multidisciplinary team approach for vascular disease: The role of cardiologists and vascular specialists Ana Paula Mollón MD Hospital Nacional A. Posadas Argentina Disclosure Speaker s name: Ana Paula

More information